Prediction of lymph node metastasis risk by M2 tumor associated macrophages in colorectal cancer tissue
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 9
Abstract
Objective To investigate the risk of lymph node metastasis (LNM) in colorectal cancer (CRC) based on the M2 macrophage activity biomarker soluble CD163 (sCD163). Methods The clinical data and preoperative blood samples of 152 patients with CRC and 58 patients with colorectal adenoma who received primary surgery in Jingmen Central Hospital from January 2018 to May 2019 were collected. Blood samples were collected the day before surgery, and enzyme-linked immunosorbent assay (ELISA) was used to measure serum levels of sCD163, carcinoembryonic antigen (CEA), and carbohydrate antigen 199 (CA199). Postoperative follow-up was conducted with a cutoff date of April 30, 2024, and the overall survival and disease-free survival were recorded. Results The level of sCD163 in patients without LNM was significantly lower than in those with LNM ［(2.79±0.76) mg/L vs (4.25±1.50) mg/L, t=7.958, P＜0.01］. Multivariate logistic regression analysis indicated that sCD163＞3.50 mg/L was an independent risk factor for LNM in CRC patients (HR=13.973, 95%CI: 5.385-36.259, P＜0.05). sCD163＞3.50 mg/L had the highest ability to predict lymph node metastasis in CRC patients (AUC=0.742), with a sensitivity of 68.8% and a specificity of 79.7%. There were 35 patients (46.1%) died in the group of sCD163＞3.50 mg/L, and 12 patients (15.8%) died in the group of sCD163≤3.50 mg/L. There was a significant difference in overall survival between the two groups (log-rank χ2=15.583, P＜0.01). There were 42 patients (55.3%) in the group of sCD163＞3.50 mg/L relapsed, and 25 patients (32.9%) in the group of sCD163≤3.50 mg/L relapsed. The difference in recurrence-free survival between the two groups was statistically significant (log-rank χ2=8.368, P=0.004). Conclusion Elevated levels of the biomarker sCD163, which reflects M2 macrophage activity in tissues, are significantly associated with LNM and poor prognosis in CRC patients, and sCD163 may be a potential predictive factor for identifying CRC patients at high risk of LNM.
Authors and Affiliations
ZHU Xiaoxuan, LONG Zhou, CAO Shaohua
Keywords
Related Articles
- EP ID EP745459
- DOI 10.13429/j.cnki.cjcr.2024.09.012
- Views 38
- Downloads 0
Diagnostic value of AFP, CEA and HSP90a in primary liver cancer based on the prediction model
Objective To construct a predictive model to analyze the diagnostic value of serum alpha fetoprotein (AFP), carcinoembryonic antigen (CEA), heat shock protein 90a (Hsp90a) for primary liver cancer (PHC). Methods A retr...
Progress of perfusion related problems and nursing in flexible ureteroscopic lithotripsy
Flexible ureteroscopic lithotripsy is the main minimally invasive surgery in the treatment of ureteral calculi, with many advantages such as little trauma, short hospitalization time and low surgical risk. However, a lar...
Therapeutic effect and risk factors for postoperative complications of endoscopic negative pressure ligation combined with sclerotherapy injection for internal hemorrhoid bleeding
Objective To investigate the clinical efficacy of endoscopic negative pressure ligation combined with sclerotherapy in the treatment of internal hemorrhoidal hemorrhage, and to analyze the risk factors of postoperative...
Research progress on the effect of chemotherapy drugs on ovarian function in breast cancer
In women with reproductive potential, ovarian dysfunction caused by chemotherapy for breast cancer has far-reaching effects. Ovarian insufficiency can manifest as amenorrhea, menstrual disorders, hot flashes and night sw...
Efficacy and prognosis of transurethral holmium laser en-blocresection of bladder tumor in the treatment of non-invasive bladder cancer
Objective To investigate the efficacy and prognosis of transurethral holmium laser en-bloc resection of bladder tumor (HOLRBT) and transurethral resection of bladder tumor (TURBT) in the treatment of non-invasive bladder...